The FDA recommends Semaglutide for weight loss if you meet one of the following criteria: Have a body mass index (BMI) of 27kg/m2 or greater and at least one weight-related condition, such as high blood pressure, Type 2 diabetes or high cholesterol Have a BMI of 30kg/m2 or greater Avoid semaglutide if you have: History of medullary thyroid cancer History of gallbladder disease History of pancreatitis Multiple endocrine neoplasia syndrome type 2 (MEN2) If youre considering semaglutide for weight loss, your first step should be consulting your primary care physician (PCP)
Medications like orforglipron (an oral, non-peptide GLP-1 agonist), survodutide (a dual glucagon/GLP-1 agonist), and CagriSema (combining cagrilintide with semaglutide) are advancing through clinical trials
Glucagon Receptor Activation : Promotes energy expenditure and fat oxidation, potentially enhancing weight loss
These aren't typical results these patients were deliberate about training and nutrition
Research observations from biochemical, recombinant-protein, cellular, ex vivo, animal or clinical-investigation settings should not be interpreted as instructions for personal use or as evidence supporting use of this research material in humans